{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:09:31Z","timestamp":1791461371990,"version":"4.3.4"},"reference-count":28,"publisher":"Scientific Scholar","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec>\n            <jats:title>Background &amp; objectives:<\/jats:title>\n            <jats:p>In India, hypertension constitutes a significant health burden. This observational, non-interventional, prospective study was conducted in five centres across India to evaluate the current clinical practices for the management of hypertension.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Participants were enrolled if they were newly diagnosed with essential hypertension or had pre-existing hypertension and were on the same therapeutic plan for the previous three months. At baseline, three months, six months, and one year, information on the patient and their treatment regimen was documented, and their quality of life (QoL) was evaluated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 2000 individuals were enrolled in this study, with a mean age of 54.45 yr. Of these, 55.7 per cent (n=1114) were males, and 957 (47.85%) were newly diagnosed with hypertension, while 1043 (52.15%) had pre-existing hypertension. Stage 2 hypertension (systolic blood pressure (BP) &gt;140 or diastolic BP \u226590 mmHg) accounted for more than 70 per cent of the participants (70.76% of pre-existing and 76.29% of newly diagnosed); the average duration of pre-existing hypertension was 68.72 months. Diabetes (31.6%) and dyslipidaemia (15.8%) were the most common comorbidities. In 43.3 per cent of the participants, monotherapy was used, and in 56.7 per cent (70.55% fixed-dose combination), combination therapy was used. Telmisartan (31.6%), amlodipine (35.2%), and a combination of the two (27.1%) were the most commonly prescribed treatment regimens. At three months, six months, and one year, treatment modifications were observed in 1.4, 1.05, and 0.23 per cent of the participants receiving monotherapy and 2.74, 4.78 and 0.35 per cent receiving combination therapy, respectively. In both groups, the proportion of individuals with controlled hypertension (\u2264140\/90 mmHg) increased by more than 30 per cent after a year. At one year, physical and emotional role functioning, social functioning, and health improved considerably.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interpretation &amp; conclusions:<\/jats:title>\n            <jats:p>Combination therapy for hypertension is increasingly preferred at the time of initial diagnosis. The efficacy, safety, and tolerance of the recommended medications were reflected by improvements in the QoL and the minimal changes in the therapeutic strategy required.<\/jats:p>\n          <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_3096_21","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T07:32:34Z","timestamp":1697527954000},"page":"244-255","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["The Indian registry on current patient profiles &amp; treatment trends in hypertension (RECORD): One year interim analysis"],"prefix":"10.25259","volume":"158","author":[{"given":"Girish Chandrakant","family":"Rajadhyaksha","sequence":"first","affiliation":[{"name":"Department of Medicine, Topiwala National Medical College & B. Y. L. Nair Charitable Hospital, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Reddy","sequence":"additional","affiliation":[{"name":"Department of Medicine, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amresh Kumar","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Oomman","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Apollo Hospitals, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srilakshmi Mandayam","family":"Adhyapak","sequence":"additional","affiliation":[{"name":"Department of Cardiology. St. John\u2019s Medical College & Hospital, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2023,9,16]]},"reference":[{"key":"R2-20241212","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ihj.2019.09.012","article-title":"Prevalence of hypertension among Indian adults:Results from the great India blood pressure survey","volume":"71","author":"Ramakrishnan","year":"2019","journal-title":"Indian Heart J"},{"key":"R3-20241212","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4103\/ijmr.IJMR_549_19","article-title":"World hypertension day:Contemporary issues faced in India","volume":"149","author":"Jose","year":"2019","journal-title":"Indian J Med Res"},{"key":"R4-20241212","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/HJH.0000000000000146","article-title":"Hypertension in India:A systematic review and meta-analysis of prevalence, awareness, and control of hypertension","volume":"32","author":"Anchala","year":"2014","journal-title":"J Hypertens"},{"key":"R5-20241212","first-page":"1552","article-title":"Determinants of hypertension among urban adult population in Kancheepuram district of Tamil Nadu determinants of hypertension among urban adult population in Kancheepuram district of Tamil Nadu","volume":"4","author":"Gopalakrishnan","year":"2017","journal-title":"IJCMPH"},{"key":"R6-20241212","doi-asserted-by":"crossref","first-page":"5491838","DOI":"10.1155\/2017\/5491838","article-title":"Prevalence and associated risk factors of hypertension:A cross-sectional study in Urban Varanasi","volume":"2017","author":"Singh","year":"2017","journal-title":"Int J Hypertens"},{"key":"R7-20241212","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults:Executive summary:A report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"R8-20241212","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension:The task force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)","volume":"36","author":"Williams","year":"2018","journal-title":"J Hypertens"},{"key":"R9-20241212","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"R10-20241212","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41371-020-0349-x","article-title":"Indian guidelines on hypertension-IV (2019)","volume":"34","author":"Shah","year":"2020","journal-title":"J Hum Hypertens"},{"key":"R11-20241212","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of Hypertension global hypertension practice guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"key":"R12-20241212","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s41182-018-0104-y","article-title":"Structural equation modeling to identify the risk factors of diabetes in the adult population of North India","volume":"46","author":"Tripathy","year":"2018","journal-title":"Trop Med Health"},{"key":"R13-20241212","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/jamainternmed.2017.8094","article-title":"Diabetes and hypertension in India:A nationally representative study of 1.3 million adults","volume":"178","author":"Geldsetzer","year":"2018","journal-title":"JAMA Intern Med"},{"key":"R14-20241212","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.4103\/jfmpc.jfmpc_234_20","article-title":"Prevalence of hypertension and diabetes morbidity among adults in a few urban slums of Bangalore city, determinants of its risk factors and opportunities for control \u2013A cross-sectional study","volume":"9","author":"Ramani","year":"2020","journal-title":"J Family Med Prim Care"},{"key":"R15-20241212","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1097\/01.hjh.0000500629.11472.af","article-title":"Dyslipidemia in hypertension- risk and prevention approach in rural population in India","volume":"34","author":"Kohli","year":"2016","journal-title":"J Hypertens"},{"key":"R16-20241212","doi-asserted-by":"crossref","first-page":"D95","DOI":"10.21276\/ijcmsr.2018.3.4.22","article-title":"Study of prevalence of dyslipidemia in newly diagnosed essential hypertension","volume":"3","author":"Gupta","year":"2018","journal-title":"IJCMSR"},{"key":"R17-20241212","doi-asserted-by":"crossref","first-page":"e1002801","DOI":"10.1371\/journal.pmed.1002801","article-title":"Hypertension screening, awareness, treatment, and control in India:A nationally representative cross-sectional study among individuals aged 15 to 49 years","volume":"16","author":"Prenissl","year":"2019","journal-title":"PLoS Med"},{"key":"R18-20241212","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/jch.14141","article-title":"India Hypertension Control Initiative-Hypertension treatment and blood pressure control in a cohort in 24 sentinel site clinics","volume":"23","author":"Kaur","year":"2021","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"R19-20241212","doi-asserted-by":"crossref","first-page":"e055226","DOI":"10.1136\/bmjopen-2021-055226","article-title":"Patient and provider's perspective on barriers and facilitators for medication adherence among adult patients with cardiovascular diseases and diabetes mellitus in India:A qualitative evidence synthesis","volume":"12","author":"Krishnamoorthy","year":"2022","journal-title":"BMJ Open"},{"key":"R20-20241212","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.clinthera.2018.12.008","article-title":"Efficacy and safety of triple therapy with telmisartan, amlodipine, and rosuvastatin in patients with dyslipidemia and hypertension:The Jeil telmisartan, amlodipine, and rosuvastatin randomized clinical trial","volume":"41","author":"Hong","year":"2019","journal-title":"Clin Ther"},{"key":"R21-20241212","first-page":"106","article-title":"Efficacy and tolerability of olmesartan, telmisartan, and losartan in patients of stage I hypertension:A randomized, open-label study","volume":"8","author":"Kalikar","year":"2017","journal-title":"J Pharmacol Pharmacother"},{"key":"R22-20241212","first-page":"525","article-title":"Assessment of efficacy, safety and tolerability of fixed dose combination of telmisartan 40 mg and hydrochlorothiazide 12.5 mg in adult Indian patients with mild to moderate hypertension","volume":"102","author":"Jayaram","year":"2004","journal-title":"J Indian Med Assoc"},{"key":"R23-20241212","first-page":"687","article-title":"The antihypertensive efficacy of chlorthalidone and telmisartan in Indian hypertensive patients who were uncontrolled with hydrochlorothiazide and telmisartan combination \u2013A prospective and an open label study","volume":"7","author":"Sagarad","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"R24-20241212","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4103\/picr.PICR_93_17","article-title":"Effect of telmisartan on blood pressure in patients of type 2 diabetes with or without complications","volume":"9","author":"Gadge","year":"2018","journal-title":"Perspect Clin Res"},{"key":"R25-20241212","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/jpcs.jpcs_7_17","article-title":"Management of hypertension:Insights into prescribing behavior with focus on angiotensin receptor blockers","volume":"3","author":"Ramakrishnan","year":"2017","journal-title":"J Pract Cardiovasc Sci"},{"key":"R26-20241212","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.17511\/ijmrr.2016.i09.30","article-title":"Comparative study of telmisartan and amlodipine to assess the effect on blood pressure, lipid profile and blood glucose level in Indian hypertensive patients","volume":"4","author":"Tripathi","year":"2016","journal-title":"Int J Med Res Rev"},{"key":"R27-20241212","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MBP.0000000000000172","article-title":"Comparison of telmisartan\/amlodipine and telmisartan\/hydrochlorothiazide in the treatment of Japanese patients with uncontrolled hypertension:The TAT-Kobe study","volume":"21","author":"Kondo","year":"2016","journal-title":"Blood Press Monit"},{"key":"R28-20241212","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1751-7176.2009.00098.x","article-title":"Results of treatment with telmisartan-amlodipine in hypertensive patients","volume":"11","author":"Littlejohn","year":"2009","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"R29-20241212","first-page":"HC08","article-title":"Comparative study of high dose mono-therapy of amlodipine or telmisartan, and their low dose combination in mild to moderate hypertension","volume":"8","author":"Goyal","year":"2014","journal-title":"J Clin Diagn Res"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ijmr.ijmr_3096_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:06:45Z","timestamp":1751497605000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/the-indian-registry-on-current-patient-profiles-treatment-trends-in-hypertension-record-one-year-interim-analysis\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_3096_21","relation":{},"ISSN":["0971-5916","0975-9174"],"issn-type":[{"value":"0971-5916","type":"print"},{"value":"0975-9174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"2021-10-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}